Watch our instructional video on how to use the mLife Verify device. 

Visual Interpretation of mLife Verify Results


• Two lines appear. One line visible in the control region (C), and another line visible in the test region (T).
• This indicates the drug concentration is below the detectable level.

• One line appears in the control region (C). No line appears in the test region (T).
• The lack of a line in the test region (T) indicates a presumptive positive result for the corresponding drug of that specific test region.

• Control line fails to appear.
• Insufficient specimen volume or incorrect procedural techniques are the most likely reason for control line failure.  

Interpretation of Results_mLife_Oral Sal
Annotation 2020-04-24 170249.jpg

Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs

Efforts to control SARS-CoV-2, the novel coronavirus causing COVID-19 pandemic, dependon accurate and rapid diagnostic testing. These tests must be ( 1 ) sensitive to mild andasymptomatic infections to promote effective self isolation and reduce transmission withinhigh risk groups 1; ( 2 ) consistent to reliably monitor disease progression and aid clinicaldecisions 2; and ( 3 ) scalable to inform local and national public health policies, such as when
social distancing measures can be safely relaxed.

Annotation 2020-04-24 170759.jpg

Consistent Detection of 2019 Novel
Coronavirus in Saliva

The 2019 novel coronavirus (2019-nCoV) was detected in the
self-collected saliva of 91.7% (11/12) of patients. Serial saliva
viral load monitoring generally showed a declining trend. Live
virus was detected in saliva by viral culture. Saliva is a promising
noninvasive specimen for diagnosis, monitoring, and infection
control in patients with 2019-nCoV infection.


Drug use and abuse are critical social issues in the United States in 2018. Two drug families in particular stand out: marijuana (cannabinoids) and opioids.

Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs